August 24, 2011
Wellesley, Mass. – In a recent release, BIOBANKING: TECHNOLOGIES AND GLOBAL MARKETS (BIO084A) from BCC Research (www.bccresearch.com), the global biobanking market was worth $141.2 billion in 2010. That number is projected to reach $183.6 billion in 2015, after increasing at a five-year compound annual growth rate (CAGR) of 5.4%.
The global biobanking market can be broken down into three main categories – disease biobanks, population biobanks, and private sector biobanks.
Disease biobanks held a market value of nearly $56.5 billion in 2010 and in 2015 that value is projected to reach nearly $60 billion, yielding a CAGR of 1.2%.
The population biobanks were worth nearly $42.3 billion in 2010, and in 2015 they are expected to be worth nearly $54 billion, a CAGR of 5%.
Private sector banks, worth nearly $42.5 billion in 2010, are projected to hold a market value of nearly $69.7 billion in 2015, after increasing at a CAGR of 10.4%.
A biobank is a collection of human biological specimens, and can include any material derived from a human subject, such as whole organs, tissue, blood, plasma, urine, or intracellular components such as DNA and RNA. Currently, biobanks are being used to accelerate the development of new drugs, medical treatments for diseases, and to develop new, better-targeted tests for specific diseases.
The biobanking market presents the largest of all opportunities in the areas of new drug and treatment development for specific diseases. This study investigates one of the most important market drivers in the biotechnology-pharmaceuticals area – the introduction to the market of a resource for investigating a variety of combined disease therapies. This is expected to contribute substantially to market growth through the forecast period, as well as another driver – growing middle classes in emerging countries such as India, China, Brazil, and Russia.
This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants, and anyone interested in the biobanking market, its products, industry participants, and future.
Biobanking: Technologies and Global Markets( BIO084A )
Publish Date: Jun 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.